i-ControlXL platform

Designed for the bioprocessing market, the i-ControlXL platform offers industrial power, reliability and expandability using standard programmable logic controllers (PLC) and distributed control systems (DCS). The platform addresses critical issues, such as high-throughput screening, scaling up and down, and the requirements of the FDA’s process analytical technology (PAT) initiative. Key features of the i-ControlXL include: intuitive navigation; a color touch-screen interface; optional bioreactor controls; optional pumps and sensors; the ability to use the same system to control autoclavable vessels; and single-use bioreactors or SIP/CIP systems. Users can choose among Siemens, Allen Bradley and Delta V controllers for their applications. Additionally, i-ControlXL uses fieldbus technology, adheres to S88 guidelines and features open system architecture.